Anastasios Maniakas, David Cognetti, Makoto Tahara, Takuma Makino, Kai-Ping Chang, Akihiro Homma, Chen-Chi Wang, Chun-Wei Huang, Dr Rajesh Kantharia, Matthew John Mifsud, Ghanishkumar Panjwani, Nobuhiro Hanai, Hassan Danesi, Toshiaki Suzuki, Shiou-Yi Ethan Chen, Haiying Dong, Dai Imamura, Rebecca Cheng, Ann M. Gillenwater, Pei-Jen Lou. "A phase 3, randomized, double-arm, open-label, controlled study of ASP-1929 photoimmunotherapy (PIT) versus physician’s choice standard of care (SOC) for patients with locoregional, recurrent head and neck squamous cell carcinoma (HNSCC).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.6080